← All candidates
One insider buy in the last year — $10.2K in all.
22 filings on record.
PSTVPLUS THERAPEUTICS, INC.
NasdaqCM · Healthcare · $29.67M
$3.98
-4.33% · Jul 2
One insider buy in the last year — $10.2K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys◆ 12 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
Reverse-split 5×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what PSTV ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$29.67M
Float
6.5M
94% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Lenk Robert P
Bought $53.8K on Aug 22 — 110,000 sh @ $0.4889, held direct, 79% of their stake.
0 of 1 position beat the S&P
Chief Financial Officer
Sims Andrew John Hugh MacIntyre
Bought $10.2K on Nov 4 — 20,000 sh @ $0.5100, held direct, 29% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
1 more transaction on Pro →The file stays open
22 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice